BCR and neoplasm: Combining scRNA-seq, CITE-seq and TCR and BCR repertoire analysis of matched blood and tumour samples allowed, the identification of different patient groups with distinct immune cell infiltration, selection, differentiation and response mechanisms within the TME, providing a rational way for the selection and design of novel immunotherapeutic interventions for PDAC patients.